Latest blog articles

Last year’s COP28 has resulted in a ‘historic’ mention of fossil fuels in its final decision, be it in a rather limited way. Where does the EU, the forerunner in climate action, stand when it comes to the elimination of fossil fuels? This post highlights a few problematic features of the EU’s policy...

How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.

It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...

Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...

Every once in a while, I have the good fortune of reading a court case which is both fun and educational. The UK Supreme Court case Ivey (Appellant) v Genting Casinos (UK) Ltd t/a Crockfords (Respondent) is one such case, which tells an interesting story, while also explaining to the public the...

​On 6 June, IGIR fellow Dr. Iveta Alexovičová, Assistant Professor of International Economic Law, Faculty of Law, Maastricht University, delivered a lecture entilted "Substance alongside procedure - a lesson learned?".